ATL-1, a synthetic analog of lipoxin, modulates endothelial permeability and interaction with tumor cells through a VEGF-dependent mechanism

Biochemical Pharmacology

Volumn 90, Issue 4, 2014, Pages 388-396

  Vieira, A M ^a   Neto, E H ^a   Figueiredo, C C ^a   Barja Fidalgo, C ^a   Fierro, I M ^a   Morandi, V ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adherens junctions; Endothelial permeability; Lipoxin; VE cadherin; VEGF

Indexed keywords

15 EPI 16 (PARAFLUORO)PHENOXY LIPOXIN A4; ATL 1; BETA CATENIN; LIPOXIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ARTICLE; CELL INTERACTION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG MECHANISM; EXTRAVASATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; MELANOMA CELL LINE; METASTASIS INHIBITION; METASTATIC MELANOMA; MODULATION; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR EXTRAVASATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADHERENS JUNCTIONS; ENDOTHELIAL PERMEABILITY; LIPOXIN; VE-CADHERIN; VEGF;

CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOXINS; MELANOMA; MICROSCOPY, FLUORESCENCE; PERMEABILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904641584     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.05.019     Document Type: Article

References (64)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer: the next generation Cell 144 2011 646 674
2. A. Eger, and W. Mikulits Models of epithelial - mesenchymal transition Drug Discov Today: Dis Models 2 2005 57 63
3. M.J. Bissell, and D. Radisky Putting tumours in context Nat Rev Cancer 1 2001 45 46
4. C.L. Addison Modulation of response to tumor therapies by the extracellular matrix Future Oncol 2 3 2006 417 429 (Pubitemid 43960114)
5. K. Polyak, I. Haviv, and I.G. Campbell Co-evolution of tumor cells and their microenvironment Trends Genet 25 2009 30 38
6. C. Michiels Endothelial cell functions J Cell Physiol 196 2003 430 443 (Pubitemid 36927738)
7. E. Dejana, M. Corada, and M.G. Lampugnani Endothelial cell-to-cell junctions FASEB J 9 1995 910 918
8. H.J. Schnittler Structural and functional aspects of intercellular junctions in vascular endothelium Basic Res Cardiol 93 Suppl. 3 1998 30 39
9. E. Dejana Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis J Clin Invest 98 9 1996 1949 1953 (Pubitemid 26376280)
10. J.S. Alexander, and J.W. Elrod Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation J Anat 200 6 2002 561 574 (Pubitemid 34823048)
11. D.R. Senger, S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 4587 1983 983 985
12. S. Koch, and L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Cold Spring Harb Perspect Med 2 2012 a006502
13. G.H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
14. N. Ferrara, H.P. Gerber, and J. LeVouter The biology of VEGF and its receptors Nat Med 9 2003 669 676 (Pubitemid 36749215)
15. S. Esser, M.G. Lampugnani, M. Corada, E. Dejana, and W. Risau Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells J Cell Sci 111 Pt 13 1998 1853 1865 (Pubitemid 28370530)
16. B. Küsters, R.M. de Waal, P. Wesseling, K. Verrijp, C. Maass, and A. Heerschap et al. Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma Cancer Res 63 17 2003 5408 5413 (Pubitemid 37139858)
17. S.M. Weis, and D.A. Cheresh Pathophysiological consequences of VEGF-induced vascular permeability Nature 437 2005 497 504 (Pubitemid 41613541)
18. M.I. Shtivelband, H.S. Juneja, S. Lee, and K.K. Wu Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression J Thromb Haemost 1 10 2003 2225 2233
19. D. Wang, and R.N. Dubois Cyclooxygenase-2: a potential target in breast cancer Semin Oncol 31 1 Suppl. (3) 2004 64 73 (Pubitemid 38543941)
20. J.R. Vane The mechanism of action of anti-inflammatory drugs Ernst Schering Res Found Workshop 31 2000 1 23
21. J. Clària, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc Natl Acad Sci U S A 92 1995 9475
22. C.N. Serhan, T. Takano, K. Gronert, N. Chiang, and C.B. Clish Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators Clin Chem Lab Med 37 3 1999 299 309 (Pubitemid 29209745)
23. N. Chiang, T. Takano, C.B. Clish, N.A. Petasis, H.H. Tai, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA J Pharmacol Exp Ther 287 2 1998 779 790 (Pubitemid 29133683)
24. R.L. Simões, and I.M. Fierro Involvement of the Rho-kinase/myosin light chain kinase pathway on human monocyte chemotaxis induced by ATL-1, an aspirin-triggered lipoxin A4 synthetic analog J Immunol 175 3 2005 1843 1850 (Pubitemid 41023090)
25. I.M. Fierro, J.I. Kutok, and C.N. Serhan Novel lipid mediator regulators of endothelial cell proliferation and migration aspirin-triggered 15-R-lipoxin-A4 and lipoxin A4 J Pharmacol Exp Ther 300 2002 385 392 (Pubitemid 34106227)
26. P.F.T. Cezar-de-Mello, A.M. Vieira, V. Nascimento-Silva, C.G. Villela, C. Barja-Fidalgo, and I.M. Fierro ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor Br J Pharmacol 153 2008 956 965 (Pubitemid 351328942)
27. P.F.T. Cezar-de-Mello, V. Nascimento-Silva, C.G. Vilela, and I.M. Fierro Aspirin-triggered lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly Oncogene 25 2006 122 129 (Pubitemid 43050010)
28. N. Baker, S.J. O'Meara, M. Scannell, P. Maderna, and C. Godson Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells J Immunol 182 6 2009 3819 3826
29. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J Clin Invest 52 11 1973 2745 2756
30. G.N. van Muijen, K.F. Jansen, I.M. Cornelissen, D.F. Smeets, J.L. Beck, and D.J. Ruiter Establishment and characterization of a human melanoma cell line (MV3) wich is highly metastatic in nude mice Int J Cancer 48 1991 85 91
31. E.W. Ades, F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, and D.C. Bosse et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line J Invest Dermatol 99 6 1992 683 690 (Pubitemid 23002027)
32. D. Hanahan, and R.A. Weinbeg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
33. J.W. Franses, A.B. Baker, V.C. Chitalia, and E.R. Edelman Stromal endothelial cells directly influence cancer progression Sci Transl Med 3 66 2011 66ra5
34. J. Folkman Angiogenesis Annu Rev Med 57 2006 1 18 (Pubitemid 43261975)
35. J.R. van Beijnum, M. Rousch, K. Castermans, E. van der Linden, and A.W. Griffioen Isolation of endothelial cells from fresh tissues Nat Protoc 3 2008 1085 1091 (Pubitemid 351818695)
36. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
37. I.M. Fierro Angiogenesis and lipoxins Prostaglandins Leukot Essent Fatty Acids 73 2005 271 275 (Pubitemid 41253486)
38. S. Weis, J. Cui, L. Barnes, and D. Cheresh Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis J Cell Biol 167 2004 223 229 (Pubitemid 39435066)
39. J.H. Tinsley, M.H. Wu, W. Ma, A.C. Taulman, and S.Y. Yuan Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells J Biol Chem 274 1999 24930 24934
40. J.A. Ukropec, M.K. Hollinger, S.M. Salva, and M.J. Woolkalis SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin J Biol Chem 275 2000 5983 5986 (Pubitemid 30115248)
41. J. Gavard, and J.S. Gutkind VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin Nat Cell Biol 8 2006 1223 1234 (Pubitemid 44660587)
42. H. Hoschuetzky, H. Aberle, and R. Kemler Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor J Cell Biol 127 1994 1375 1380 (Pubitemid 24362569)
43. R.W. McLachlan, and A.S. Yap Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts J Mol Med 85 2007 545 554 (Pubitemid 46870898)
44. J. Rhee, T. Buchan, L. Zukerberg, J. Lilien, and J. Balsamo Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription Nat Cell Biol 9 2007 883 892 (Pubitemid 47190443)
45. M. Yamaoka-Tojo, T. Tojo, H.W. Kim, L. Hilenski, N.A. Patrushev, and L. Zhang et al. 1.IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis Arterioscler Thromb Vasc Biol 26 9 2006 1991 1997 (Pubitemid 44253779)
46. A. Hartsock, and W.J. Nelson Adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis Biochim biophys Acta 1778 2008 660 669 (Pubitemid 351317795)
47. J. Gavard Breaking the VE-cadherin bonds FEBS Lett 583 2009 1 6
48. N. Gavert, and A. Ben-Ze'ev A beta-Catenin signaling in biological control and cancer J Cell Biochem 102 2007 820 828 (Pubitemid 350036922)
49. V. Easwaran, S.H. Lee, L. Inge, L. Guo, C. Goldbeck, and E. Garrett et al. Beta-Catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res 63 2003 3145 3153 (Pubitemid 36735866)
50. E. Dejana, F. Orsenigo, and M.G. Lampugnani The role of adherens junctions and VE-cadherin in the control of vascular permeability J Cell Sci 121 2008 2115 2122
51. M.D. Potter, S. Barbero, and D.A. Cheresh Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state J Biol Chem 280 36 2005 31906 31912 (Pubitemid 41291941)
52. F. Orsenigo, C. Giampietro, A. Ferrari, M. Corada, A. Galaup, and S. Sigismund et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo Nat Commun 3 2012 1208
53. A.P. Adam, A.L. Sharenko, K. Pumiglia, and P.A. Vincent Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers J Biol Chem 285 10 2010 7045 7055
54. R. Nawroth, G. Poell, A. Ranft, S. Kloep, U. Samulowitz, and G. Fachinger et al. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts EMBO J 21 18 2002 4885 4895
55. C. Jean, X.L. Chen, J.O. Nam, I. Tancioni, S. Uryu, and C. Lawson et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function J Cell Biol 204 2 2014 247 263
56. García-Román, and Zentella-Dehesa Vascular permeability changes involved in tumor metastasis Cancer Lett 335 2 2013 259 269
57. J.A. Nagy, E.M. Masse, K.T. Herzberg, M.S. Meyers, K.T. Yeo, and T.K. Yeo et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation Cancer Res 55 2 1995 360 368
58. C.D. Liu, L. Tilch, D. Kwan, and D.W. McFadden Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer J Surg Res 102 1 2002 31 34
59. S. Hiratsuka, S. Goel, W.S. Kamoun, Y. Maru, D. Fukumura, and D.G. Duda et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation Proc Natl Acad Sci U S A 108 9 2011 3725 3730
60. H. Arias-Pulido, N. Chaher, Y. Gong, C. Qualls, J. Vargas, and M. Royce Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer BMC Cancer 19 12 2012 298
61. K.P. Claffey, L.F. Brown, L.F. del Aguila, K. Tognazzi, K.T. Yeo, and E.J. Manseau et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 56 1996 172 181 (Pubitemid 26010397)
62. S.R. Palmer, L.A. Erickson, I. Ichetovkin, D.J. Knauer, and S.N. Markovic Circulating serologic and molecular biomarkers in malignant melanoma Mayo Clin Proc 86 10 2011 981 990
63. Y. Chen, H. Hao, S. He, L. Cai, Y. Li, and S. Hu et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of anti-angiogenesis Mol Cancer Ther 9 2010 2164 2174
64. B.P. Eliceiri, R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh Selective requirement for Src kinases during VEGF induced angiogenesis and vascular permeability Mol Cell 4 1999 915 924 (Pubitemid 30054898)